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The present study was designed to explore the potent antioxidant of crude methanol extract (CME) of 
Feronia limonia bark and its four fractions such as petroleum ether (PEF), chloroform (CLF), ethyl 
acetate (EAF) and aqueous fractions (AQF) in the treatment of neurodegenerative disorders, caused by 
oxidative stress. The highest phenolic and flavonoid content were detected in CLF (18.16 µg of gallic 
acid equivalent/gm of dried sample &160.20 µg of GAE/gm of extract) suggestive for good source of 
antioxidant. To the best of the knowledge, the compound C-1, Umbelliferone (7-hydroxycoumarin), 
reported for the first time from this plant source, was isolated & characterized from the chloroform 




C-NMR and HMBC respectively. All the 
fractions and the compound isolated were investigated for in vitro antioxidant activity by total 
antioxidant capacity assay, ferric reducing power assay, 1,1-diphenyl-2-picrylhydrazyl(DPPH) free 
radical & hydroxyl radical scavenging assay and lipid peroxidation assay. The total antioxidant activity 
and reducing capacity of CLF & EAF was higher than CME, AQF & PEF. In case of DPPH assay, all 
the extracts tested exhibited strong and similar free radical scavenging activity (IC50 values 15.8-17.4 
µg/ml) compared with the reference standard ascorbic acid(IC50 value 12.6 µg/ml). The AQF had the 
highest hydroxyl radical scavenging activity with IC50 value 12.5 µg/ml. The isolated compound and 
seven column fractions (F2 to F8) of CLF also possessed good antioxidant activity. The highest lipid 
peroxidation inhibition capacity was found from F7 (IC50 value 14 µg/ml) appearing more potent than 
the standard catechin. Irrefutably, the study revealed that the plant bark inhibits multiple components of 
the oxidative stress pathway, which is suggestive for using in the effective and safe treatment of 
neurodegenerative diseases after in vivo effectiveness test is done.   
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Neurodegenerative disorders are a heterogeneous group of chronic and progressive diseases that are 
characterized by abnormalities of relatively specific regions of the brain and the specific population of neurons [1-3]. 
The mechanism of neuronal damage in neurodegenerative disorders that have been elucidated include neuronal 
apoptosis, abnormal protein deposition, mitochondrial mechanisms of cell death, generation of reactive oxygen 
species(ROS) and oxidative stress related signaling [4]. One of the major changes found in essentially all 
neurodegenerative diseases is the over expression of ROS like superoxide anion radical(O2
-
), hydrogen 
peroxide(H2O2) & hydroxyl radical(OH
o
), singlet oxygen, nitric oxide radical, hypochlorite radical, various lipid 
peroxides and other free radicals that lead to oxidative stress and cell death [5]. All the markers of oxidative stress 
have been documented in neurodegenerative disorders including Alzheimer’s diseases [6-8] & Parkinson’s disease 
[9-11]. Over production of ROS induces cellular and molecular abnormalities in these diseases including 
peroxidation of lipid, oxidation of protein, enzyme as well as DNA along with decrease in superoxide dismutase 
(SOD), catalase, glutathione peroxidation and reduced glutathione level [12].  
The human body’s antioxidants are capable to mop up free radical by neutralizing them, as a result free radical or 
ROS induced cell damage is prevented. But the process is effective in case of vast production of free radicals that 
may not happen always [13, 14]. Antioxidants in food have received a great amount of attention as they possess 
primary preventive ingredients against various diseases [15, 16]. Therefore, antioxidant therapies foreseeing the 
reduction of oxidative damage and the increase of endogenous antioxidant defenses have been suggested to prevent, 
delay or ameliorate the diseases symptoms [4]. 
Currently available synthetic antioxidants like butylated hydroxyl anisole (BHA), butylated hydroxyl 
toluene(BHT), tertiary butylated hydroquinone and gallic acid esters are efficient against ROS, but concurrently 
cause prompt negative health effects like liver damage and mutagenesis. As a result, strong restriction has been 
placed on their application [17-20]. At present there is special interest on naturally occurring antioxidants derived 
from the plant sources which are candidates in the treatment of oxidative damage. Compounds isolated from plant 
possess ideal structural chemistry for free radical scavenging activity, and shown to be more effective antioxidants in 
vitro are used for the treatment of neurodegenerative disorders [4]. Recently, a number of plant products including 
phenolic and flavonoid contents as well as various crude extracts of plants were reported for antioxidant actions [21-
25]. 
Feronia limonia bark ,locally called Kath bel bark, belonging to the Family, Rutaceae, widely distributed in 
indomalya ecogone, Bangladesh, India, Pakistan,  Sri Lanka, Indochinese ecoregion, Java, Malaysia ecoregion, has 
been used for centuries in folk medicine to treat anorexia, bronchitis, calculus, cardiac debility, cough, diarrhea, 
gastropathy, fever, tuberculosis , toothaches and as antiemetic, aromatic, astringent, carminative, cardiotonic, 
expectorant, purgative, alexipharmic and are useful in pruritus and pharyngodynia. The plant is also useful for 
asthma, consumption, tumors, opthalmia, leucorrhoea, scurvy and sore throat. Fruit pulp is sour, sweet, edible 
stomachic, stimulant and astringent. The bark is aromatic, having cooling sensation and is useful in vitiated 
conditions of pitta. The bark is occasionally prescribed for biliousness and useful in liver disease [26-28]. The 
different parts of the plant have been investigated by several workers and found to contain coumarins, 
furanocoumarins, lignans, alkaloids, steroids and flavonoids. The unripe fruits contain stigmasterol. Root bark 
yieldedosthol, geranyl umbelliferone, marmin, marmesin, aurapten,bergapten, isopimpinellin and fernoil. The 
heartwood contains ursolic acid and a flavanone glycoside 7-methylporiol-b-Dxylopyranosyl-D-glucopyranoside. 
The stem bark of F. limonia yielded flavanone, alkaloids, coumarins, lignan, sterols and triterpene. Psoralen, 
bergapten, orientin, vitexin and saponarin have been isolated from leaves [29-35]. 
Previous studies have shown that the methanolic extract of the bark exhibit strong antioxidant activity [35]. In 
continuation of the study, the present work was designed to investigate the methanolic extract of the bark using 
conventional chromatographic technique to explore the potent antioxidants which may have the sufficient capacity to 
fight against the neurodegenerative disorders. 
 
2. Materials and Methods 
2.1. Plant material and Extraction Preparation 
Fresh Bark of Feronia limonia were collected in the vicinity of Rajshahi University, Bangladesh in the month of 
February, 2012. Authentication was achieved by the comparison with the herbarium specimen deposited in the 
herbarium of the Dept. of Botany of the same university. The plant materials were washed with water, cut into 
pieces, shade dried for several days , then dried in an oven for 24 hours below 60°C and pulverized in coarse powder 
using a grinder. The powdered plant material (700 gm) was extracted with cold methanol(2 L), then filtered, 
squeezed off and evaporated off under reduced pressure in a rotary evaporator to obtain crude methanol extract 
(CME, 20gm). An aliquot of the concentrated methanolic extract was further partitioned with petroleum ether, 
chloroform, ethyl acetate and water. The resultant fractions i.e., pet ether (PEF, 4.54 gm), chloroform (CLF, 9.28 
gm), ethyl acetate (EAF, 5.68 gm) and water (AQF, 8.5 gm) soluble fractions were used for next experimental work. 
 
2.2. Phytochemical Screening 
The presence of various classes of active chemical constituents such as alkaloids, steroids, glycosides, saponins, 
tanins etc. in all extractives were determined by color test, Libermann-Buchard’s test, general test, lead acetate test, 
frothing test respectively using standard procedures [36]. 
 
2.3. Determination of Total Phenolic Content 
Total phenolic content of different fractions of F. limonia were measured according to the Folin-Ciocalteu 
method [37]. Briefly, the samples solution (0.5 mL) at different concentrations (ranging from 100 to 1100 μg/mL) 
was mixed with 2.58 mL of Folin-Ciocalteu’s phenol reagent. After 3 min, 0.3 mL of saturated sodium carbonate 




solution was added to the mixture. The reaction mixtures were incubated at room temperature (25°C) for 20 min. The 
absorbance was measured at 760 nm with a spectrophotometer. Gallic acid solutions with concentrations ranging 
from 25 to 400 μg/mL were used for calibration. A dose response linear regression was generated by using the gallic 
acid standard absorbance and the levels in the samples were expressed as gallic acid equivalents (mg of GAEs/g of 
extract). The estimation was performed in triplicate, and the results were expressed as mean ± SD. 
 
2.4. Determination of Total Flavonoid Content  
The total flavonoid content of different fractions so prepared was estimated by following the procedure by 
Garrett and Grisham [38]. Briefly, one ml of aqueous extract containing 0.1 gm/m of dry matter was placed in a 10 
ml volumetric flask, then 5 ml of distilled water added followed by 0.3 ml of 5% NaNO2. After another 5 minutes, 6 
ml of 10% AlCl3 was added and volume made up with distilled water. The solution was mixed well and absorbance 
was measured at 510 nm. The total flavonoid content was calculated using standard catechin calibration curve. The 
results were expressed as milligrams of catechin equivalents (CE) per gram of dried extract.  
 
2.5. Isolation and Identification of Compound 
The chloroform fraction (9gm) was subjected to column chromatography for further fractionation. A well –
stirred suspension of silica gel (120 gm in n-hexane) was poured into column (height 36 cm and diameter 5.5 cm). 
When the adsorbent was well settled, the excess of n-hexane was allowed to pass through the column followed by 
applying the CLF as free flowing mass made from silica gel to top of column. The column was eluted with a mobile 
phase of increasing polarity: n-hexane/chloroform/EtOAc/MeOH. Depending on the TLC behavior eight different 
column fractions (F-1 to F-8) were finally obtained for further analysis from 339 fractions. The pure Compound-I (C-
I) dark brown gummy mass was isolated from F-3(47.4 mg) & F-6(43.7 mg) fractions in solvent system, n-hexane: 
chloroform (1:3) with Rf 
  
value 0.552 using TLC followed by PTLC technique. The other fractions were not 
undergone any further chemical investigation due to small quantity. 
 
2.6. In Vitro Antioxidant Assay 
2.6.1. Determination of Total Antioxidant Capacity 
Total antioxidant capacity of different extractives and isolated compound, column fractions(F-2 to F-8) of L. 
feronia were measured spcetrophotometrically thorough phosphomolybdenum method by Prieto, et al. [39] with 
some modifications. The assay was based on the reduction of Mo(VI) – Mo(V)  by all extractives and subsequent 
formation of a green reagent phosphate/ Mo(V)  complex at acidic pH [40]. Briefly, an aliquot of 0.5 ml of sample 
solution was combined with 3 ml of reagent solution (0.6 M sulphuric acid, 28 mM sodium phosphate and 1% 
ammonium molybdate). The tubes were incubated at 95
0
 c for 90 minutes. The mixture was cooled to room 
temperature and the absorbance of aqueous solution of each was measured at 695 mm against a blank (3 ml of 
reagent solution). The assay were carried out in triplicate and expressed as mean ± SD. The antioxidant activity was 
expressed as the absorbance of the sample. 
 
2.6.2. DPPH Free Radical Scavenging Assay 
The free radical scavenging activity of the extract, isolated compound as well as their various fractions was 
evaluated according to Braca et al. [41, 42]. Briefly, sample solution with different concentrations (ranging from 0 to 
200 μg/mL) was mixed with 0.3% of DPPH methanol solution. The reaction mixtures were incubated at room 
temperature and allowed to react for 30 minutes in the dark. After 30 min, the absorbance values were measured at 
517 nm and converted into percentage of antioxidant activity. Ascorbic acid (AA) was used as a positive control. The 
percentage of inhibition of DPPH (%) was calculated as follows: 
% inhibition of DPPH = Diff x 100/Absorbance of control  
Where, Diff = Absorbance of control – Absorbance of test sample 
The concentration of sample required to scavenge 50% of the DPPH free radical (IC50) was determined from the 
curve of % inhibitions plotted against the respective concentration. 
 
2.6.3. Hydroxyl Radical Scavenging Assay 
Hydroxyl radical scavenging activity of different extractives of this plant bark was determined by the method 
described by Elizabeth and Rao [43]. 1 ml of reaction mixture was made by adding 2-deoxy-D-ribose (2.8 mM); 
KH2PO4-KOH (20 mM, pH 7.4); FeCl3 (100 µM) and various conc. (6.25 -100 µgm/ml) of the test sample or 
reference compound. After incubation for 1 hr. at 37
0
 c, 0.5 ml of the reaction mixture was added to 1 ml of 2.8% 
trichloroacetic acid (TCA). Then 1 ml of 1% aqueous thiobarbituric acid (TBA) was added and the mixture was 
incubated at 90
0
 c for 15 min to develop the color. After cooling the absorbance was measured at 532 nm against an 
appropriate blank solution (the same solution mixture without plant extract or std. undergone same incubation). The 
percentage inhibition activity was calculated from the following equation: 
% I = {(A0 – A1)/A0} x 100, where, A0  and A1   are the absorbance of the control and extract/standard respectively. 
IC 50 was measure from the graph of % inhibition against various concentrations. 
 
2.6.4. Lipid Peroxidation Inhibition Assay 
The inhibition of lipid peroxidation assay of the isolated compound and all extractives of said plant bark was 
determined against according to the method as described by Liu [44] with slight modification. In assay, the brain of 
adult long Evan rats (av. weight 150 gm) were homogenized with a homogenizer in ice-cold phosphate buffer (50 
mM,pH 7.4) to produce 1/10 homogenate followed by centrifugation at 10000 rpm for 15 min at 4
0
 c. The 
supernatant so produced was used as liposome. The ability of plant extract to inhibit lipid peroxidation was studied 
by incubating homogenates treated with hydrogen peroxide (10 µM) and different conc. of plant extracts. Hydrogen 




peroxide induces lipid peroxidation in rat brain homogenates. Lipid peroxides react TBA to form a pink product, 
thiobarbituric acid reacting substances measurable to calorimetrically at 532 nm. The difference between the control 
and plant extract treated sample is the measurement of decrease in TBARS formation, reflecting the reduction of 
hydroxyl radical induced lipid peroxidation. 
 
2.6.5. Reducing Power Capacity Assessment  
The reducing power of bark extract of the plant was determined according to the method as described by Oyaizu 
[45]. Aliquot (1 ml) of samples solution at different concentrations (ranging from 12.5 to 100 μg/mL) was mixed 
with 2.5 mL of 0.2 M phosphate buffer (pH 6.6) and 2.5 ml of 1% (w/v) solution of potassium ferricyanide. After 
mixing well, all the mixtures were warmed in a water bath at 50°C for 20 min. Then, 2.5 ml of 10% (w/v) 
trichloroacetic acid solution was added and the mixture was then centrifuged at 2000 rpm for 10 min. The 
supernatant (2.5 ml) was combined with 2.5 ml of distilled water, and 0.5 ml 0.1% (w/v) ferric chloride solution was 
added. The absorbance was measured at 700 nm with a spectrophotometer against blank (the same solution mixture 
without the plant extract or positive control). Ascorbic acid was used as positive control. All the tests were run in 
triplicate and results were reported as mean ± SD. A higher absorbance of reaction mixture indicates a higher 
reducing power. 
 
3. Result  
The phytochemical screening of all the extracts of Feronia limonia showed that saponin, tannin, alkaloids, 
glycosides & steroids were present in CME & EAF in varying extent but, AQF, PEF & CLF contained glycosides & 
steroid only in moderate amount with absence of other bioactive compounds. All the extractives contained reportable 
amount of phenol and flavonoid (Table 1). Total phenolic and flavonoid content of CME were 13.26 mg of GAE/gm 
& 78.37 mg of CE/gm. Among the different fractions of CME, highest phenolic & flavonoid content was found from 
CLF (18.16 µg of GAE/gm of dried extract & 160.20 µg of GAE/gm of extract, respectively) (Table 1). 
 
Table-1. Total phenolic and flavonoid content of all extractives of Feronia limonia bark. 
Extracts Total  Phenolic content Total Flavonoid content 
CME 13.26±0.71(mg) 78.37±1.614(mg) 
CLF 18.16±0.90(µg) 160.20±0.90(µg) 
EAF 12.15±1.5(µg) 120.56±3.86(µg) 
PEF 12.09±0.93(µg) 98.33±3.34(µg) 
AQF 10.81±0.77(µg) 109.44±1.93(µg) 
CME= Crude methanol extract, CLF, EAF, PEF, AQF= Chloroform, Ethyl acetate, Pet-ether, Aqueous fraction 
respectively. 
 
Characterization of the Compound, C-1 
Repeated chromatographic separation and purification of chloroform fraction of crude methanol extract of the 





HMBC spectral data. The compound was isolated as gummy mass, dark brown in color, soluble in acetone, 
chloroform, ethyl acetate, and methanol (slightly); but insoluble in pet-ether with Rf value 0.552 in n-
Hexane/chloroform (1:3) solvent system and showed positive test with vanillin/sulfuric acid spray reagent indicating 
the character of higher alcohol or phenol or essential oil. 
Umbelliferone: Dark brown, gummy mass; 
1
H (500 MHz, CDCl3) δ ppm: 7.62 ( 1H, d, J= 7.6 Hz),  7.34 (1H,d, 
J= 6.8 Hz), 6.83 (1H,d, J 6.8 Hz), 6.80 (1H, s), 6.23 (1H, d, J= 7.6 Hz); 
13
C-NMR (100 MHz, CDCl3) δc, ppm: 
162.2(C-2), 161.3(C-7), 155.1(C-9), 144.5(C-4), 129.2(C-5), 118.4(C-10), 113.2(C-6), 112.9(C-3) & 101.5(C-8) 
 
 




H spectrum showed the presence of impurities with major peaks that were identified based on coupling 
constants as three protons on substituted benzene ring at δ ( in ppm) 7.34 (1H,d, J= 6.8 Hz), 6.83 (1H,d, J 6.8 Hz) 
and 6.80 (1H, s). These three protons signals are probably due to the presence of 1, 2, 4-trisubstituted benzene ring. 
The 
1
H spectrum also showed the presence of 1, 2,-disubstituted cis-olefin protons at δ 7.62 ppm ( 1H, d, J= 7.6 Hz) 
and 6.23 (1H, d, J= 7.6 Hz). Considering these spectral data with 
13
C-NMR spectral data extracted (δ 162.2, 161.3, 
155.1, 144.5, 129.2, 118.4, 113.2, 112.9 & 101.5) from impurities suggested the presence of 7-hydroxy coumarin 
moiety in the skeleton. Also the HMBC spectrum showed no correlation between aromatic parts of the spectrum with 
the up fielded carbons. Hence, based on the above short discussion, the most probable structure consistent with all 
these date seemed to be 7-hydroxycoumaring or umbelliferone (Fig. 1). The NMR data of FL-8-3 was in good 
concurrence with those reported in literature of umbelliferone [258-259]. However, to confirm the complete structure 




of the impure part, more purification is needed to take 2D NMR data (gHMBC, gHSQC and NOE) that will be 
reported elsewhere.
 
 The results of DPPH free radical scavenging assay used as one of the test method of antioxidant activity 
demonstrated that CME, its CLF, EAF, PEF & AQF fractions and C-1  exhibited better free radical scavenging 
activity( IC50 values 17.4µg/ml, 16.8 µg/ml, 17 µg/ml,  16.2 µg/ml, 15.8 µg/ml, 17.4 µg/ml respectively) than that of, 
Column fractions, F-2 – F8(IC50 values, 22.4 µg/ml, 27 µg/ml, 31 µg/ml, 23.6 µg/ml, 18.6 µg/ml, 33.2 µg/ml, 26 
µg/ml respectively) ( Fig.-2). The scavenging activity was increased with increment of concentration (Fig.-2). The 
total antioxidant capacity was measured by phosphomolybdate radical scavenging test. For crude extract, all fractions 
and for compound, phosphomolybdate radical scavenging activity was found increased with higher concentrations. 
Highest phosphomolybdate radical scavenging activity was found for F-8 fraction (Fig. 3). The CLF also showed 
significant phosphomolybdate radical scavenging activity. In case of hydroxyl radical scavenging activity test, 
among all samples, F-2 fraction showed highest activity (IC50 value 6 µg/ml) which appeared to more potent than 
reference standard catechin (IC50 value 8.8 µg/ml). Other samples also showed considerable activity, shown in Fig. 4. 
The result of lipid peroxidation inhibitory activity was presented in Fig. 5. In comparison, CME possesses the highest 
inhibitory effect (IC50 value 29 µg/ml) against brain lipid peroxidation than its fractions CLF, EAF, AQF, PEF (IC50 
value 49µg/ml, 61µg/ml, 63µg/ml, 80 µg/ml). Among all samples, F-7 showed the highest inhibition with IC50 value 
of 14 µg/ml which appeared to be more potent than standard catechin (IC50 value 16µg/ml). Reductive capabilities of 
CME, all fractions, & the compound were shown in Fig.6. The reducing power of CME, all fractions, & the 
compound was increased gradually with the increase in concentrations. Among all samples, at highest test conc. (100 
µg/ml), the highest reducing power capacity was shown by C-1 & F-2 fraction with absorbance of 3.04 & 3.03 
respectively proving approximately as potent as standard catechin (absorbance 3.5). Higher absorbance is an 




Fig-2. A. DPPH radical scavenging activity of crude methanolic extract of Feronia  limonia, its four fractions and std. ascorbic acid. B. DPPH 




Fig-3. A. Total antioxidant activity of crude methanolic extract of Feronia  limonia, its four fractions and std. catechin. B. Total antioxidant 
activity of compound (C-1) & column fractions (F 2 to F8). 
 





Fig-4. A. Hydroxyl radical scavenging activity of crude methanolic extract of Feronia  limonia, its four fractions and std. catechin.. B. 




Fig-5. A. Lipid peroxidation inhibitory activity of crude methanolic extract of Feronia  limonia, its four fractions and std. catechin.. B. Lipid 




Fig-6. A. Reducing power capacity of crude methanolic extract of Feronia  limonia, its four fractions and std. catechin.. B Reducing power 
capacity of compound (C-1) & column fractions (F 2 to F8). 
 
4. Discussion 
Although several mechanism of neurodegeration have been proposed, the generation of reactive oxygen species 
and oxidative damage is implicated in the pathogenesis of neurodegenerative disorders [46-48]. Antioxidants therapy 
plays an colossal role in the reduction of oxidative damage and increase of endogenous antioxidant defenses 
suggestive for prevention, delay or upgrade the disease symptoms. Considering this phenomena the present study 




was done with a view to isolate completely new plant source’s antioxidant which may have capacity in the 
management of oxidative stress mediated any kind of disorders. Crude methanolic extract of bark of this plant, its 
four fractions were undergone the phytochemical analysis which showed the presence of various bioactive 
compounds like phenolic, flavonoid, alkaloid, saponin, glycoside, tannin and steroids. Due to high content of 
phenolics & flavonoid, the chloroform fraction was further investigated by column chromatography followed by 




C-NMR & HMBC and 
seven column fractions, F-2 to F-8. One of the most noticeable matters of this study is that umbelliferone is isolated 
for the first time from this particular plant source.  
DPPH free radical scavenging activity assay, the most popular spectrophotometric methods for determination of 
the antioxidant capacity of food, beverages and vegetable extracts was used for evaluating the antioxidant proper of 
all extractives, compound and the column fractions [49]. The isolated compound showed the most significant DPPH 
free radical scavenging activity. In total antioxidant activity, chloroform fraction exhibited the highest activity. As 
free hydroxyl radical is considered a factor in neurodegenerative diseases due to its toxicity and role in various 
chemical reaction, all the plant samples were undergone hydroxyl scavenging activity test, the result of which 
demonstrated that the column fraction, F-2, C-1 and F-6 had the strong activity. Although all the fractions exhibited 
appreciable lipid peroxidation activity, the highest activity was shown by F 7 foreshadowing more potent than the 
standard catechin. These results point that Feronia limonia is a good source of lipid peroxidation scavenging. 
To end with, the in vitro studies portends that Feronia limonia inhibits multiple components of the oxidative 
stress pathways that can be the cause of neurodegenerative diseases. The chloroform fraction of the plant appears to 
be good source of strong antioxidant possibly due to high content of phenolic compounds and flavonoids. Although 
the in vivo effectiveness remains to be investigated, the strong antioxidant activity of the compound C-1 which is 
appeared for the first time in this plant and potent column fractions isolated from the chloroform fractions may prove 
useful for an effective and safe treatment of neurodegenerative diseases.  
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